MANK

COM:MANKINDPHARMA

Mankind Pharma

  • Stock

Last Close

2,574.40

21/11 10:00

Market Cap

848.24B

Beta: -

Volume Today

275.52K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Mar '20
Mar '21
Mar '22
Mar '23
Mar '24
net income
14.38B
-
16.92B
17.66%
19.75B
16.73%
12.82B
35.08%
23.99B
87.18%
depreciation and amortization
990.59M
-
1.19B
20.10%
1.67B
40.05%
3.26B
95.57%
3.98B
22.21%
deferred income tax
stock based compensation
231.86M
-
change in working capital
-1.45B
-
-946.33M
34.84%
-5.86B
519.36%
1.67B
128.45%
204.16M
87.76%
accounts receivables
-3.09B
-
2.00B
164.83%
-659.53M
132.94%
-2.05B
211.30%
-2.90B
41.20%
inventory
-781.49M
-
-2.84B
263.92%
-5.77B
102.78%
2.62B
145.39%
-550.03M
121.01%
accounts payables
1.83B
-
-781.53M
142.67%
4.20B
637.18%
-650.19M
115.49%
974.52M
249.88%
other working capital
586.10M
-
676.93M
15.50%
-3.63B
636.67%
1.75B
148.25%
2.68B
52.83%
other non cash items
-3.22B
-
-5.79B
79.80%
-6.35B
9.78%
101.33M
101.60%
-835.00M
924.01%
net cash provided by operating activities
10.70B
-
11.37B
6.31%
9.20B
19.12%
17.85B
94.02%
21.52B
20.61%
investments in property plant and equipment
-2.28B
-
-3.12B
37.00%
-23.46B
651.01%
-8.32B
64.53%
-3.82B
54.05%
acquisitions net
52.97M
-
102.70M
93.88%
207.45M
102.00%
22.21M
89.30%
73.95M
233.02%
purchases of investments
-5.73B
-
-9.96B
73.89%
-11.86B
19.11%
-9.49B
19.98%
-16.30B
71.82%
sales maturities of investments
4.86B
-
3.77B
22.34%
16.78B
344.77%
7.12B
57.55%
5.45B
23.50%
other investing activites
-1.30B
-
-3.02B
132.61%
4.63B
253.53%
-4.09M
100.09%
-6.68B
162,964.48%
net cash used for investing activites
-4.39B
-
-12.22B
178.31%
-13.69B
12.02%
-10.67B
22.08%
-20.82B
95.12%
debt repayment
-2.15B
-
-4.68B
118.31%
-6.54B
39.59%
-6.95B
6.32%
-339.64M
95.11%
common stock issued
common stock repurchased
dividends paid
-3.64B
-
other financing activites
481.10M
-
4.61B
857.50%
12.59B
173.21%
-30.03M
100.24%
net cash used provided by financing activities
-5.31B
-
-78.11M
98.53%
6.05B
7,840.62%
-6.98B
215.49%
52.66M
100.75%
effect of forex changes on cash
36.04M
-
3.75M
89.59%
4.78M
27.47%
-171.58M
3,689.58%
11.66M
106.80%
net change in cash
1.03B
-
-924.03M
189.35%
1.56B
268.53%
22.87M
98.53%
771.87M
3,275.47%
cash at beginning of period
1.16B
-
2.20B
88.91%
1.27B
42.05%
3.03B
137.60%
3.05B
0.76%
cash at end of period
2.20B
-
1.27B
42.05%
2.83B
122.31%
3.05B
7.69%
3.82B
25.32%
operating cash flow
10.70B
-
11.37B
6.31%
9.20B
19.12%
17.85B
94.02%
21.52B
20.61%
capital expenditure
-2.28B
-
-3.12B
37.00%
-23.46B
651.01%
-8.32B
64.53%
-3.82B
54.05%
free cash flow
8.42B
-
8.25B
2.00%
-14.26B
272.83%
9.53B
166.81%
17.70B
85.83%

All numbers in (except ratios and percentages)